HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis

INTRODUCTION: BMS-663068 is a prodrug of BMS-626529, an attachment inhibitor that binds directly to HIV-1 gp120, preventing initial viral attachment and entry into the host CD4+ T-cell. AI438011 is a Phase IIb, randomized, active-controlled trial investigating the safety, efficacy and dose–response...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Int AIDS Soc
Prif Awduron: Brinson, Cynthia, Lalezari, Jacob, Gulam, Latiff H, Thompson, Melanie, Echevarria, Juan, Treviño-Pérez, Sandra, Stock, David, Samit, Joshi R, George, Hanna J, Lataillade, Max
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International AIDS Society 2014
Pynciau:
Oral Presentation – Abstract O432A
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224901/
https://ncbi.nlm.nih.gov/pubmed/25394038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19529
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg